1,230 Spam-Free Article(s) Found
Article Searches
Lilly (LLY) Tops on Q1 Earnings, Raises '18 View, Stock Up http://www.zacks.com/stock/news/300433/lilly-lly-tops-on-q1-earnings-raises-18-view-stock-up?cid=CS-ZC-FT-300433 Apr 24, 2018 - Eli Lilly (LLY) beats estimates for both earnings and sales in Q1 and raises guidance for 2018. Shares rise in pre-market trading.
Celgene: Bold Pursuits In Science With 24.66% Discount https://seekingalpha.com/article/4164871-celgene-bold-pursuits-science-24_66-percent-discount?source=feed_sector_healthcare Apr 23, 2018 - Celgene is positioning a master plan to grow beyond 2020.It is accelerating its diversification and expecting a strong volume-driven growth in 2018 while conveying a solid track record.The current dis
Q1 Earnings Surprise Well in Cards: Healthcare ETFs to Buy http://www.zacks.com/stock/news/300249/q1-earnings-surprise-well-in-cards-healthcare-etfs-to-buy?cid=CS-ZC-FT-300249 Apr 23, 2018 - Let's dig into the earnings picture of the companies that would drive the performance of the popular health care ETFs in the coming days.
How To Retire At 65 With Only Half A Million https://seekingalpha.com/article/4164602-retire-65-half-million?source=feed Apr 23, 2018 - Seeking Alpha helps retirees and future retirees face current issues.Today, I will be going over investor priorities and fears when planning for the future.Dividend investing is a great source of inco
Does Dicerna's Settlement Agreement With Alnylam Make It A Buy? https://seekingalpha.com/article/4164722-dicernas-settlement-agreement-alnylam-make-buy?source=feed_sector_healthcare Apr 23, 2018 - Dicerna settles a dispute between it and Alnylam over trade secrets. The settlement will allow Dicerna to continue its operations as planned with a total of $25 million given to Alnylam in cash and st
Stocks To Watch: Earnings Blockbusters And Trump Talks Drug Prices https://seekingalpha.com/article/4164569-stocks-watch-earnings-blockbusters-trump-talks-drug-prices?source=feed Apr 21, 2018 - Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
What's in the Cards for Glaxo (GSK) This Earnings Season? http://www.zacks.com/stock/news/300060/whats-in-the-cards-for-glaxo-gsk-this-earnings-season?cid=CS-ZC-FT-300060 Apr 20, 2018 - Strong sales in Glaxo's (GSK) Pharmaceuticals and Vaccines business segment might aid the company's results in Q1.
Pharma Stock Roundup: NVS, JNJ Q1 Sales & Earnings Top, MRK & BMY Active at AACR http://www.zacks.com/stock/news/300053/pharma-stock-roundup-nvs-jnj-q1-sales-earnings-top-mrk-bmy-active-at-aacr?cid=CS-ZC-FT-300053 Apr 20, 2018 - Novartis (NVS) and J&J (JNJ) deliver strong Q1 results. Merck (MRK) and Bristol Myers (BMY) present lung cancer data at AACR.
Lilly (LLY) to Report Q1 Earnings: What's in the Cards? http://www.zacks.com/stock/news/300046/lilly-lly-to-report-q1-earnings-whats-in-the-cards?cid=CS-ZC-FT-300046 Apr 20, 2018 - Lilly's (LLY) new drugs like Trulicity, Taltz and Jardiance have been performing well. Let's see if these along with its older products lead the company to an earnings beat.
J&J, Novartis' Q1 Earnings Impress: Will Others Follow Suit? http://www.zacks.com/stock/news/300037/jj-novartis-q1-earnings-impress-will-others-follow-suit?cid=CS-ZC-FT-300037 Apr 20, 2018 - Johnson & Johnson (JNJ) and Novartis reported strong first-quarter 2018 earnings results earlier this week.

Pages: 123456...123

Page 1>
DeepLinks for Merck & Company
MRK - Google Finance https://www.google.com/finance?q=MRK Industry related info and international coverage Summary News
MRK - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=MRK Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options